U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H19NO5
Molecular Weight 329.3478
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of N-FERULOYL DOPAMINE, TRANS-

SMILES

COc1cc(ccc1O)/C(/[H])=C(\[H])/C(=NCCc2ccc(c(c2)O)O)O

InChI

InChIKey=ZRLYUFOWFPPSTD-QPJJXVBHSA-N
InChI=1S/C18H19NO5/c1-24-17-11-12(3-6-15(17)21)4-7-18(23)19-9-8-13-2-5-14(20)16(22)10-13/h2-7,10-11,20-22H,8-9H2,1H3,(H,19,23)/b7-4+

HIDE SMILES / InChI

Molecular Formula C18H19NO5
Molecular Weight 329.3478
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Patents
Substance Class Chemical
Created
by admin
on Fri Jun 25 22:34:37 UTC 2021
Edited
by admin
on Fri Jun 25 22:34:37 UTC 2021
Record UNII
NGL0OTK5E8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-FERULOYL DOPAMINE, TRANS-
Common Name English
2-PROPENAMIDE, N-(2-(3,4-DIHYDROXYPHENYL)ETHYL)-3-(4-HYDROXY-3-METHOXYPHENYL)-, (2E)-
Systematic Name English
N-FERYLOYLDOPAMINE
Common Name English
TRANS-FERULOYLDOPAMINE
Common Name English
2-PROPENAMIDE, N-(2-(3,4-DIHYDROXYPHENYL)ETHYL)-3-(4-HYDROXY-3-METHOXYPHENYL)-, (E)-
Systematic Name English
Code System Code Type Description
EPA CompTox
142350-99-0
Created by admin on Fri Jun 25 22:34:37 UTC 2021 , Edited by admin on Fri Jun 25 22:34:37 UTC 2021
PRIMARY
FDA UNII
NGL0OTK5E8
Created by admin on Fri Jun 25 22:34:37 UTC 2021 , Edited by admin on Fri Jun 25 22:34:37 UTC 2021
PRIMARY
PUBCHEM
16119330
Created by admin on Fri Jun 25 22:34:37 UTC 2021 , Edited by admin on Fri Jun 25 22:34:37 UTC 2021
PRIMARY
CAS
142350-99-0
Created by admin on Fri Jun 25 22:34:37 UTC 2021 , Edited by admin on Fri Jun 25 22:34:37 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
440 uM IC50 vs in vitro prostaglandin synthesis
PARENT -> CONSTITUENT ALWAYS PRESENT
Among the compounds tested in this study, N-coumaroyldopamine and N-caffeoyldopamine were the two most potent compounds, able to increase cAMP at the concentrations < 0.05 uM in U937 cells. The decreasing order of potency was N-coumaroyldopamine > N- affeoyldopamine > N-feruloyldopamine > N-sinapoyldopamine > N-cinnamoyldopamine.